ProfileGDS5822 / ILMN_2453058
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 26% 3% 16% 12% 14% 13% 7% 24% 5% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 114.526
GSM1276600PDAC Late Ablation Control 28.23
GSM1276601PDAC Late Ablation Control 35.316
GSM1276602PDAC Late Ablation 19.512
GSM1276603PDAC Late Ablation 21014
GSM1276604PDAC Late Ablation 39.313
GSM1303940PDAC Late Ablation_anti-CTLA4 18.47
GSM1303941PDAC Late Ablation_anti-CTLA4 212.124
GSM1303942PDAC Late Ablation_anti-CTLA4 345